All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Page last updated:
24 May 2021
Updated guidance from the British Association of Sexual and HIV (BASSH) recommends that testing for PID is extended to include Mycoplasma genitalium to direct the choice of antibiotics. Until access to this test is routinely available to primary care in Devon, patients with suspected PID should be referred to specialist Genito-Urinary Medicine (GUM) services for full assessment; including testing, contact tracing, and treatment management.
A diagnosis of PID should be considered and referral to the GUM services for full assessment, in any sexually active woman who has recent onset, lower abdominal pain associated with local tenderness on bimanual vaginal examination, in whom pregnancy has been excluded and no other cause for the pain has been identified. The risk of PID is highest in women aged under 25 not using barrier contraception and with a history of a new sexual partner. The diagnosis of PID based only on positive examination findings, in the absence of lower abdominal pain, should only be made with caution
Symptoms
The following features are suggestive of a diagnosis of PID
Signs
The differential diagnosis of lower abdominal pain in a young woman includes:
Sexual Health Contact Details:
Current and recent partners (within the last 6 months) of women with PID should be contacted and offered advice, screening, treatment, and contact tracing, this may include empirical therapy for partners e.g. doxycycline 100mg twice daily for 7 days.
All patients should be advised not to have sex until they and any current partners have completed antibiotic treatment.
Refer to hospital for inpatient management if the patient:
Exclude pregnancy prior to consideration of antibiotic treatment.
Patients with suspected PID should be referred to specialist GUM services for 1st line treatment with ceftriaxone IM plus oral doxycycline and metronidazole. The GUM service will conduct testing and contact tracing.
If the person declines, or is unable to attend a GUM service, and either intramuscular administration of ceftriaxone is not possible in primary care or is not clinically appropriate, the oral only antibiotic regimen below may be considered.
If the patient is to be treated in primary care, the following steps should be taken:
Before starting treatment:
PLUS
PLUS
See sections 5.1.2 Cephalosporins, carbapenems, and other beta-lactams, 5.1.3 Tetracyclines, and 5.1.11 Metronidazole
Review the patient at 72 hours. If no improvement, consider a referral to hospital.
Consider further review, either in clinic or by phone, 2 weeks after treatment to assess clinical response, compliance and partner treatment. If symptoms have not resolved, refer to the GUM service for assessment.
Test of cure is only necessary if initial testing for gonorrhoea was positive; see Management of gonorrhoea.